SCHEMBL8317405

SCHEMBL8317405

O=C(OCc1ccccc1)N1C=CCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
CYP2C19 P33261 1/20 0.47
HTR2C P28335 1/20 0.45
P2RX4 Q99571 2/20 0.44
ALDH1A1 P00352 3/20 0.44
P2RX1 P51575 1/20 0.43
P2RX3 P56373 1/20 0.43
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31552127 0.96 KMT2A (0.49) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL2767868 0.91 KMT2A (0.52) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL6073259 0.85 KMT2A (0.52) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL10560040 0.81 KMT2A (0.51) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL25081030 0.79 MEN1 (0.60) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL25081032 0.79 KMT2A (0.53) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL504559 0.78 MEN1 (0.56) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL3183682 0.77 SMN1; SMN2 (0.57) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL11453000 0.77 NPC1 (0.52) KMT2AMEN1NPSR1NPC1RAB9A
SCHEMBL3071662 0.75 SMN1; SMN2 (0.63) KMT2AMEN1NPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739655-A2 SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER Nestor, Marika (SE) 2026-05-13 EP disclosed
WO-2025008409-A2 SUBSTITUTED 2-PHENYLPIPERIDINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF CANCER JHA PREETI (US) 2025-01-09 WO disclosed
CN-107580595-B Heterocyclic compounds and their use in the prevention or treatment of bacterial infections 拜欧蒂姆公司 2020-09-18 CN disclosed
WO-2013149996-A9 SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS ALMIRALL, S.A. (ES) 2014-02-20 WO disclosed
EP-0630887-B1 4-(aryl-substituted)-piperidines as neurokinin receptor antagonists ZENECA LTD (GB) 1999-07-28 EP disclosed
US-5654299-A TREATING RESPIRATORY SYSTEM DISORDER (I.E. ASTHMA) WITH NEUROKININ 2 RECEPTOR ANTAGONIST ZENECA LIMITED (GB) 1997-08-05 US disclosed
EP-0630887-A1 4-(aryl-substituted)-piperidines as neurokinin receptor antagonists ZENECA LIMITED (GB) 1994-12-28 EP disclosed